| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |